NGS 自动化市场规模、份额和成长分析（按产品类型、应用、定序类型、最终用户和地区）- 产业预测，2025-2032

2023 年全球 NGS 自动化市场规模为 40 万美元，预计将从 2024 年的 45 万美元成长到 2032 年的 124 万美元，预测期间（2025-2032 年）的复合年增长率为 13.4%。

下一代定序 (NGS)，也称为高通量定序，与传统方法相比，它能够快速且经济高效地进行 DNA 和 RNA 分析，从而彻底改变基因组学和分子生物学。透过先进的液体处理设备实现的NGS自动化，可确保资料的一致性和可重复性，同时减少时间和成本，从而提高文库製备品质。这种自动化过程最大限度地减少了人与样品的接触，从而降低了污染的风险。随着对高效工作流程的需求不断增长，人们大幅转向自动化 NGS 流程来提高生产力并减少错误。 NGS 市场主要受其在药物开发中的应用以及主要企业可能会影响整体市场的成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

NGS 自动化市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 工作站/机器人平台
• 试剂和耗材

NGS 自动化市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 药物研发
• 临床诊断
• 肿瘤学
• 感染疾病
• 生殖健康
• 其他临床诊断
• 其他用途

NGS 自动化市场规模（依定序类型和复合年增长率） (2025-2032)

• 市场概况
• 全基因组序列分析
• 全EXOME定序
• 标靶基因测序
• 其他的

NGS 自动化市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院和诊断实验室
• 製药和生物技术公司
• 学术研究所
• 其他最终用户

NGS 自动化市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Roche Holding AG（Switzerland）
• Danaher Corporation（USA）
• Tecan Group Ltd.（Switzerland）
• Hamilton Company（USA）
• Eppendorf AG（Germany）
• Hudson Robotics（USA）
• 10x Genomics, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Honeywell International Inc.（USA）
• Siemens AG（Germany）
• Abbott Laboratories（USA）
• LabCorp（Laboratory Corporation of America Holdings）（USA）
• Charles River Laboratories International, Inc.（USA）
• Brooks Life Sciences（USA）

结论和建议

Global NGS Automation Market size was valued at USD 0.4 million in 2023 and is poised to grow from USD 0.45 million in 2024 to USD 1.24 million by 2032, growing at a CAGR of 13.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as high-throughput sequencing, is revolutionizing genomics and molecular biology by enabling rapid and cost-effective DNA and RNA analysis compared to traditional methods. Automation in NGS, facilitated by advanced liquid handling devices, enhances library preparation quality by ensuring consistent and reproducible data while reducing time and costs. This automation minimizes human interaction with samples, thereby decreasing contamination risks. As the demand for efficient workflows grows, there is a notable shift towards automated NGS processes to boost productivity and reduce errors. The NGS market is primarily driven by its applications in drug development and comprehensive offerings from key industry players, despite challenges such as high product costs and potential recalls impacting overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ngs Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ngs Automation Market Segmental Analysis

Global NGS Automation Market is segmented by Product, Application, Sequencing Type, End User and region. Based on Product, the market is segmented into Workstation/Robotic Platform and Reagents & Consumables. Based on Application, the market is segmented into Drug Discovery, Clinical Diagnostics, Oncology, Infectious Diseases, Reproductive Health, Other Clinical Diagnostics and Other Applications. Based on Sequencing Type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Genome Sequencing and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories,Pharmaceuticaland Biotechnology Companies, Academic Research Institutes and Others End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ngs Automation Market

The global NGS automation market is primarily driven by heightened investment in healthcare infrastructure, which is essential for facilitating advancements in automated NGS workflows. Factors such as the rising prevalence of cancer, increased research and development expenditure, and escalating healthcare costs further contribute to the market's growth. Additionally, the expanding applications of next-generation sequencing and the formation of corporate partnerships aimed at enhancing library preparation methods are expected to propel the industry forward. As NGS continues to prove its efficacy in comprehensive genome analysis and the identification of novel viral variants, its role in epidemiological studies, especially in distinguishing between COVID-19, influenza, and other viruses, will be crucial. Collectively, these elements are poised to drive significant growth in the NGS automation sector in the coming years.

Restraints in the Global Ngs Automation Market

The growth of the global NGS automation market is expected to be significantly hindered by the substantial costs associated with installing automation workstations. Key challenges include regulatory hurdles and the lack of standardization in diagnostic testing, alongside the requirement for highly skilled personnel to effectively manage automation software. Additionally, various legal and ethical issues related to DNA sequencing, including concerns about identifiability, informed consent, and the potential for stigmatization, pose further barriers. These ethical dilemmas, coupled with cultural sensitivities, ultimately restrict the market's expansion and limit its overall development potential.

Market Trends of the Global Ngs Automation Market

The Global NGS Automation market is witnessing a significant upward trend, fueled by the increasing demand for streamlined and efficient sequencing processes. Automation in NGS library preparation enhances the reliability and reproducibility of data by facilitating better library quality and maximizing yields. It not only boosts productivity and cuts costs but also minimizes the risk of contamination through reduced manual handling of reagents and samples. As researchers increasingly seek high-throughput solutions to cope with growing genomic data, the NGS automation market is set to expand, driven by technological advancements and the need for stringent quality control in genetic studies and diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global NGS Automation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Workstation/Robotic Platform
• Reagents & Consumables

Global NGS Automation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Clinical Diagnostics
• Oncology
• Infectious Diseases
• Reproductive Health
• Other Clinical Diagnostics
• Other Applications

Global NGS Automation Market Size by Sequencing Type & CAGR (2025-2032)

• Market Overview
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Genome Sequencing
• Others

Global NGS Automation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Others End Users

Global NGS Automation Market Size & CAGR (2025-2032)

• North America (Product, Application, Sequencing Type, End User)
  • US
  • Canada
• Europe (Product, Application, Sequencing Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Sequencing Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Sequencing Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Sequencing Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hudson Robotics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeywell International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (Laboratory Corporation of America Holdings) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations